Corporate Profile

At Talis, we strive to deliver excellence in point of care diagnostics by increasing access to timely and accurate testing that can help combat the spread of known and emerging infectious diseases.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases

18 Mar '21
Talis Appoints Jeryl Hilleman to Board of Directors
MENLO PARK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced the appointment of Jeryl “Jeri” Hilleman to its Board of

View More

Recent Events

View More

Executive Team

Brian Coe, M.B.A.

Brian Coe

Chief Executive Officer, Co-Founder

Karen E. Flick, J.D., Ph.D.

Karen E. Flick, J.D., Ph.D.

Chief of Staff and Senior Vice President, Legal

Roger Moody, M.B.A.

Roger Moody

Chief Financial Officer

Rob Kelley

Rob Kelley

Chief Commercial Officer

View More